CW Advisors LLC Grows Stake in Intuitive Surgical, Inc. $ISRG

Key Points

• CW Advisors LLC increased their stake in Intuitive Surgical, Inc. by 7.2% during the first quarter, now owning a total of 48,306 shares worth approximately $23.93 million.
• Thirteen investment analysts rated Intuitive Surgical's stock as a "Buy" while the consensus target price is $595.95, reflecting confidence in the company's growth potential.
• Intuitive Surgical reported $2.19 earnings per share for the last quarter, exceeding analysts' expectations, with revenue climbing 21.4% year-over-year to $2.44 billion.

CW Advisors LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 7.2% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,306 shares of the medical equipment provider's stock after purchasing an additional 3,233 shares during the period. CW Advisors LLC's holdings in Intuitive Surgical were worth $23,931,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. AlphaCore Capital LLC lifted its position in Intuitive Surgical by 4.2% in the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after purchasing an additional 18 shares during the last quarter. Second Line Capital LLC lifted its position in Intuitive Surgical by 3.4% in the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock valued at $302,000 after purchasing an additional 19 shares during the last quarter. Colonial Trust Co SC lifted its position in Intuitive Surgical by 8.8% in the fourth quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock valued at $128,000 after purchasing an additional 20 shares during the last quarter. Crown Wealth Group LLC lifted its position in Intuitive Surgical by 4.8% in the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock valued at $218,000 after purchasing an additional 20 shares during the last quarter. Finally, FSM Wealth Advisors LLC lifted its position in Intuitive Surgical by 3.8% in the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock valued at $270,000 after purchasing an additional 20 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Gary S. Guthart sold 2,800 shares of the stock in a transaction on Monday, July 28th. The stock was sold at an average price of $495.24, for a total value of $1,386,672.00. Following the completion of the sale, the insider directly owned 18,520 shares in the company, valued at approximately $9,171,844.80. This represents a 13.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,839 shares of company stock valued at $7,896,972 over the last ninety days. Company insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on ISRG shares. Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Royal Bank Of Canada reissued an "outperform" rating and set a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday. BTIG Research boosted their target price on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. Wells Fargo & Company boosted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research note on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft cut Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their target price for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Thirteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Price Performance

ISRG stock traded up $6.28 during midday trading on Friday, hitting $476.16. The stock had a trading volume of 2,023,902 shares, compared to its average volume of 1,973,062. The firm has a market cap of $170.69 billion, a price-to-earnings ratio of 66.41, a price-to-earnings-growth ratio of 4.99 and a beta of 1.59. The business has a 50-day moving average of $504.42 and a two-hundred day moving average of $521.58. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm's revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.78 earnings per share. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.